search
Back to results

Identification of Genetic Factors Implicated in Orofacial Cleft Using Whole Exome Sequencing (GENEPIC)

Primary Purpose

Cleft Lip and Palate

Status
Recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
identification of genetic factors
Sponsored by
Centre Hospitalier Universitaire, Amiens
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Cleft Lip and Palate focused on measuring Cleft Lip and Palate, CL/P, WES

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Subject with a NSCL/P or CL/P of unknown etiology,
  • national health care insurance holders

Exclusion Criteria:

  • Subject with a CL/P of known etiology,
  • Subject with a NSCL/P and an IRF6 mutation

Sites / Locations

  • CHU Amiens PicardieRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Identification of genetic factors

Arm Description

Clinical questionnaire and analysis of genetic data obtained by exome high-throughput sequencing

Outcomes

Primary Outcome Measures

Identification of genetic factors
Identification of genetic factors implicated in orofacial cleft using whole exome sequencing (WES).

Secondary Outcome Measures

Full Information

First Posted
February 23, 2017
Last Updated
February 9, 2023
Sponsor
Centre Hospitalier Universitaire, Amiens
search

1. Study Identification

Unique Protocol Identification Number
NCT03065686
Brief Title
Identification of Genetic Factors Implicated in Orofacial Cleft Using Whole Exome Sequencing
Acronym
GENEPIC
Official Title
Identification of Genetic Factors Implicated in Orofacial Cleft Using Whole Exome Sequencing GENEPIC
Study Type
Interventional

2. Study Status

Record Verification Date
February 2023
Overall Recruitment Status
Recruiting
Study Start Date
November 30, 2016 (Actual)
Primary Completion Date
November 30, 2023 (Anticipated)
Study Completion Date
November 30, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Centre Hospitalier Universitaire, Amiens

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Despite significant progress made in identification on numerous genes and gene pathways critical for craniofacial development, several approaches, ie mutation screening of specific candidates, association studies and even genome-wide scans have largely failed to reveal the molecular basis of NS human clefting
Detailed Description
Despite significant progress made in identification on numerous genes and gene pathways critical for craniofacial development, several approaches, ie mutation screening of specific candidates, association studies and even genome-wide scans have largely failed to reveal the molecular basis of NS human clefting. Moreover, the efficiency of Whole Exome Sequencing -WES- was proven. The efficiency of WES was proven by the identification of the genes causing Freeman Sheldon and Miller's syndrome, followed by several others. In the Picardy region, management and follow-up of orofacial cleft patients are well-organised by a multidisciplinary team in the university hospital of Amiens. The investigators therefore decided to perform whole exome sequencing (WES) on precisely phenotyped non-syndromic CL/P patients followed in our center.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cleft Lip and Palate
Keywords
Cleft Lip and Palate, CL/P, WES

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
30 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Identification of genetic factors
Arm Type
Experimental
Arm Description
Clinical questionnaire and analysis of genetic data obtained by exome high-throughput sequencing
Intervention Type
Genetic
Intervention Name(s)
identification of genetic factors
Intervention Description
Clinical questionnaire and analysis of genetic data obtained by exome high-throughput sequencing
Primary Outcome Measure Information:
Title
Identification of genetic factors
Description
Identification of genetic factors implicated in orofacial cleft using whole exome sequencing (WES).
Time Frame
Day 1

10. Eligibility

Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Subject with a NSCL/P or CL/P of unknown etiology, national health care insurance holders Exclusion Criteria: Subject with a CL/P of known etiology, Subject with a NSCL/P and an IRF6 mutation
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Bénédicte DEMEER, MD
Phone
+33 3 22 08 75 81
Email
demeer.benedicte@chu-amiens.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Bénédicte DEMEER, MD
Organizational Affiliation
CHU Amiens
Official's Role
Principal Investigator
Facility Information:
Facility Name
CHU Amiens Picardie
City
Amiens
ZIP/Postal Code
80054
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Bénédicte DEMEER, MD
Phone
+33 3 22 08 75 81
Email
demeer.benedicte@chu-amiens.fr

12. IPD Sharing Statement

Learn more about this trial

Identification of Genetic Factors Implicated in Orofacial Cleft Using Whole Exome Sequencing

We'll reach out to this number within 24 hrs